CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Gros David-Alexandre C Chief Executive Officer | Grant or award | +354,454 | 363,454 | ||
| 2026-07-31 | Gros David-Alexandre C Chief Executive Officer | Shares withheld for taxes | −194,791 | $3.38 | $658K | 168,663 |
| 2025-01-10 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-01-10 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Restricted Stock Units | +66,500 | 66,500 | ||
| 2024-11-21 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,015,743 | 1,015,743 | ||
| 2024-06-13 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +517,454 | 517,454 | ||
| 2023-05-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Common Stock (right to buy) | +383,299 | 383,299 | ||
| 2023-02-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2023-02-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +153,600 | 153,600 | ||
| 2022-02-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2021-12-20 | Gros David-Alexandre C Chief Executive Officer | Purchase | +2,000 | $4.48 | $9K | 9,000 |
| 2021-08-17 | Gros David-Alexandre C Chief Executive Officer | Purchase | +4,000 | $6.21 | $25K | 7,000 |
| 2021-06-09 | Gros David-Alexandre C Chief Executive Officer | Purchase | +3,000 | $8.01 | $24K | 3,000 |
| 2020-09-11 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +18,278.14 | 18,278.14 |
Page 1 of 1 · 14 trades